World

Top 413 largest Companies in the Drug Manufacturers—Specialty & Generic industry in the World by Market Cap

This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry in the world by market capitalization with links to their reference stock.

World Drug Manufacturers—Specialty & Generic Industry Analysis
World Top Companies World Companies Analysis

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2026

Rank Company Market Cap (USD) Country Sector Industry
211 Shaanxi Kanghui Pharmaceutical Co. Ltd $298.6 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
212 Deva Holding A.S. $293.3 M Turkey Turkish Healthcare Turkish Drug Manufacturers—Specialty & Generic
213 Alimera Sciences, Inc. $290.8 M

(July 1, 2024)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
214 Cipher Pharmaceuticals Inc. $276.1 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
215 Fuji Pharma Co. Ltd $274.4 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
216 Fine Foods & Pharmaceuticals N.T.M. S.p.A. $268.1 M Italy Italian Healthcare Italian Drug Manufacturers—Specialty & Generic
217 Laboratorio Reig Jofre, SA $253.9 M Spain Spanish Healthcare Spanish Drug Manufacturers—Specialty & Generic
218 Benchmark Holdings plc $252.1 M

(July 1, 2025)

 United Kingdom UK Healthcare UK Drug Manufacturers—Specialty & Generic
219 Aurora Cannabis Inc. $244.8 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
220 Dawnrays Pharmaceutical $241.4 M Hong Kong HK Healthcare HK Drug Manufacturers—Specialty & Generic
221 Organigram Holdings Inc. $233.5 M Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
222 Formosa Laboratories, Inc. $228.4 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
223 Ouro Fino Saude Animal Participacoes SA $221.2 M Brazil Brazilian Healthcare Brazilian Drug Manufacturers—Specialty & Generic
224 Koa Shoji Holdings Co.,Ltd. $214.5 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
225 China Chemical & Pharmaceutical Co. Ltd $211.1 M

(July 1, 2024)

 Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
226 Orient Pharma Co. Ltd $206.8 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
227 AFT Pharmaceuticals Limited $204.7 M

(July 1, 2024)

 New Zealand NZ Healthcare NZ Drug Manufacturers—Specialty & Generic
228 Mizuho Medy Co.,Ltd. $202.1 M Japan Japanese Healthcare Japanese Drug Manufacturers—Specialty & Generic
229 China SXT Pharmaceuticals, Inc. $202.0 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
230 Labomar S.p.A. $201.8 M

(July 1, 2023)

 Italy Italian Healthcare Italian Drug Manufacturers—Specialty & Generic
231 Gage Growth Corp $193.8 M

(March 1, 2022)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
232 Columbia Care, Inc. $192.6 M

(July 1, 2023)

 United States US Healthcare US Drug Manufacturers—Specialty & Generic
233 Elion Energy Company Ltd $186.2 M

(July 1, 2024)

 China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
234 EQL Pharma AB $185.5 M Sweden Swedish Healthcare Swedish Drug Manufacturers—Specialty & Generic
235 SCI Pharmtech, Inc. $185.2 M Taiwan Taiwanese Healthcare Taiwanese Drug Manufacturers—Specialty & Generic
236 PT Kimia Farma $173.3 M Indonesia Indonesian Healthcare Indonesian Drug Manufacturers—Specialty & Generic
237 RIV Capital Inc. $170.8 M

(Aug. 1, 2021)

 Canada Canadian Healthcare Canadian Drug Manufacturers—Specialty & Generic
238 Probiotec Limited $160.1 M

(Jan. 1, 2024)

 Australia Australian Healthcare Australian Drug Manufacturers—Specialty & Generic
239 Jilin Province Huinan Changlong Bio-pharmacy Company Ltd $156.2 M China Chinese Healthcare Chinese Drug Manufacturers—Specialty & Generic
240 Jeil Pharmaceutical Co.,Ltd $152.6 M South Korea South Korean Healthcare South Korean Drug Manufacturers—Specialty & Generic

Top Drug Manufacturers—Specialty & Generic Companies in the World as of Jan. 01, 2026

211. Shaanxi Kanghui Pharmaceutical Co. Ltd

Company Profile: Shaanxi Kanghui Pharmaceutical Co. Ltd
Market Cap (USD): $298.6 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

212. Deva Holding A.S.

Company Profile: Deva Holding A.S.
Market Cap (USD): $293.3 M
Country: Turkey
Sector: Turkish Healthcare
Industry: Turkish Drug Manufacturers—Specialty & Generic

213. Alimera Sciences, Inc.

Company Profile: Alimera Sciences, Inc.
Market Cap (USD): $290.8 M (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

214. Cipher Pharmaceuticals Inc.

Company Profile: Cipher Pharmaceuticals Inc.
Market Cap (USD): $276.1 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

215. Fuji Pharma Co. Ltd

Company Profile: Fuji Pharma Co. Ltd
Market Cap (USD): $274.4 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

216. Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Company Profile: Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Market Cap (USD): $268.1 M
Country: Italy
Sector: Italian Healthcare
Industry: Italian Drug Manufacturers—Specialty & Generic

217. Laboratorio Reig Jofre, SA

Company Profile: Laboratorio Reig Jofre, SA
Market Cap (USD): $253.9 M
Country: Spain
Sector: Spanish Healthcare
Industry: Spanish Drug Manufacturers—Specialty & Generic

218. Benchmark Holdings plc

Company Profile: Benchmark Holdings plc
Market Cap (USD): $252.1 M (July 1, 2025)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Drug Manufacturers—Specialty & Generic

219. Aurora Cannabis Inc.

Company Profile: Aurora Cannabis Inc.
Market Cap (USD): $244.8 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

220. Dawnrays Pharmaceutical

Company Profile: Dawnrays Pharmaceutical
Market Cap (USD): $241.4 M
Country: Hong Kong
Sector: HK Healthcare
Industry: HK Drug Manufacturers—Specialty & Generic

221. Organigram Holdings Inc.

Company Profile: Organigram Holdings Inc.
Market Cap (USD): $233.5 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

222. Formosa Laboratories, Inc.

Company Profile: Formosa Laboratories, Inc.
Market Cap (USD): $228.4 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

223. Ouro Fino Saude Animal Participacoes SA

Company Profile: Ouro Fino Saude Animal Participacoes SA
Market Cap (USD): $221.2 M
Country: Brazil
Sector: Brazilian Healthcare
Industry: Brazilian Drug Manufacturers—Specialty & Generic

224. Koa Shoji Holdings Co.,Ltd.

Company Profile: Koa Shoji Holdings Co.,Ltd.
Market Cap (USD): $214.5 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

225. China Chemical & Pharmaceutical Co. Ltd

Company Profile: China Chemical & Pharmaceutical Co. Ltd
Market Cap (USD): $211.1 M (July 1, 2024)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

226. Orient Pharma Co. Ltd

Company Profile: Orient Pharma Co. Ltd
Market Cap (USD): $206.8 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

227. AFT Pharmaceuticals Limited

Company Profile: AFT Pharmaceuticals Limited
Market Cap (USD): $204.7 M (July 1, 2024)
Country: New Zealand
Sector: NZ Healthcare
Industry: NZ Drug Manufacturers—Specialty & Generic

228. Mizuho Medy Co.,Ltd.

Company Profile: Mizuho Medy Co.,Ltd.
Market Cap (USD): $202.1 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Drug Manufacturers—Specialty & Generic

229. China SXT Pharmaceuticals, Inc.

Company Profile: China SXT Pharmaceuticals, Inc.
Market Cap (USD): $202.0 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

230. Labomar S.p.A.

Company Profile: Labomar S.p.A.
Market Cap (USD): $201.8 M (July 1, 2023)
Country: Italy
Sector: Italian Healthcare
Industry: Italian Drug Manufacturers—Specialty & Generic

231. Gage Growth Corp

Company Profile: Gage Growth Corp
Market Cap (USD): $193.8 M (March 1, 2022)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

232. Columbia Care, Inc.

Company Profile: Columbia Care, Inc.
Market Cap (USD): $192.6 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Drug Manufacturers—Specialty & Generic

233. Elion Energy Company Ltd

Company Profile: Elion Energy Company Ltd
Market Cap (USD): $186.2 M (July 1, 2024)
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

234. EQL Pharma AB

Company Profile: EQL Pharma AB
Market Cap (USD): $185.5 M
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Drug Manufacturers—Specialty & Generic

235. SCI Pharmtech, Inc.

Company Profile: SCI Pharmtech, Inc.
Market Cap (USD): $185.2 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Drug Manufacturers—Specialty & Generic

236. PT Kimia Farma

Company Profile: PT Kimia Farma
Market Cap (USD): $173.3 M
Country: Indonesia
Sector: Indonesian Healthcare
Industry: Indonesian Drug Manufacturers—Specialty & Generic

237. RIV Capital Inc.

Company Profile: RIV Capital Inc.
Market Cap (USD): $170.8 M (Aug. 1, 2021)
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Drug Manufacturers—Specialty & Generic

238. Probiotec Limited

Company Profile: Probiotec Limited
Market Cap (USD): $160.1 M (Jan. 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Drug Manufacturers—Specialty & Generic

239. Jilin Province Huinan Changlong Bio-pharmacy Company Ltd

Company Profile: Jilin Province Huinan Changlong Bio-pharmacy Company Ltd
Market Cap (USD): $156.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Drug Manufacturers—Specialty & Generic

240. Jeil Pharmaceutical Co.,Ltd

Company Profile: Jeil Pharmaceutical Co.,Ltd
Market Cap (USD): $152.6 M
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Drug Manufacturers—Specialty & Generic

Stay in touch